Vista Energy S.A.B. de C.V. (VIST)

Handsome oil prices aid Matador's (MTDR) upstream operations. However, the company is exposed to volatility in commodity prices.

Upgrades According to Truist Securities, the prior rating for International Paper Co (NYSE:IP) was changed from Hold to Buy. In the second quarter, International Paper showed an EPS of $0.59, compared to $1.24 from the year-ago quarter. The current stock performance of International Paper shows a 52-week-high of $41.89 and a 52-week-low of $29.00. Moreover, at the end of the last trading period, the closing price was at $33.72. According to B of A Securities, the prior rating for Nutanix Inc (NASDAQ:NTNX) was changed from Neutral to Buy. Nutanix earned $0.24 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $36.71 and a 52-week-low of $19.97. At the end of the last trading period, Nutanix closed at $33.75. For Enphase Energy Inc (NASDAQ:ENPH), Seaport Global upgraded the previous rating of Neutral to Buy. For the second quarter, Enphase Energy had an EPS of $1.47, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $339.88 and a 52-week-low of $116.86. At the end of the last trading period, Enphase Energy closed at $123.97. For European Wax Center Inc (NASDAQ:EWCZ), Piper Sandler upgraded the previous rating of Neutral to Overweight. European Wax Center earned $0.11 in the second quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $20.70 and a 52-week-low of $12.02. At the end of the last trading period, European Wax Center closed at $17.24. Baird upgraded the previous rating for HealthEquity Inc (NASDAQ:HQY) from Neutral to Outperform. HealthEquity earned $0.53 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $79.16 and a 52-week-low of $48.86. HealthEquity closed at $70.97 at the end of the last trading period. According to JP Morgan, the prior rating for New Jersey Resources Corp (NYSE:NJR) was changed from Underweight to Neutral. New Jersey Resources earned $0.10 in the third quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $55.84 and a 52-week-low of $38.23. At the end of the last trading period, New Jersey Resources closed at $42.17. For Five9 Inc (NASDAQ:FIVN), Deutsche Bank upgraded the previous rating of Hold to Buy. For the second quarter, Five9 had an EPS of $0.52, compared to year-ago quarter EPS of $0.34. The current stock performance of Five9 shows a 52-week-high of $89.58 and a 52-week-low of $46.63. Moreover, at the end of the last trading period, the closing price was at $66.42. According to Morgan Stanley, the prior rating for Buenaventura Mining Co Inc (NYSE:BVN) was changed from Equal-Weight to Overweight. Buenaventura Mining Co earned $0.03 in the second quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Buenaventura Mining Co shows a 52-week-high of $8.92 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $8.26. According to Keefe, Bruyette & Woods, the prior rating for Truist Financial Corp (NYSE:TFC) was changed from Market Perform to Outperform. Truist Finl earned $0.95 in the second quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Truist Finl shows a 52-week-high of $53.34 and a 52-week-low of $25.56. Moreover, at the end of the last trading period, the closing price was at $28.37. See all analyst ratings upgrades. Downgrades According to William Blair, the prior rating for Splunk Inc (NASDAQ:SPLK) was changed from Outperform to Market Perform. Splunk earned $0.71 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $125.91 and a 52-week-low of $65.00. Moreover, at the end of the last trading period, the closing price was at $119.59. For Seelos Therapeutics Inc (NASDAQ:SEEL), Guggenheim downgraded the previous rating of Buy to Neutral. In the second quarter, Seelos Therapeutics showed an EPS of $0.22, compared to $0.20 from the year-ago quarter. The current stock performance of Seelos Therapeutics shows a 52-week-high of $1.66 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.31. According to Argus Research, the prior rating for Silk Road Medical Inc (NASDAQ:SILK) was changed from Buy to Hold. Silk ...Full story available on Benzinga.com

Inflation and volatility in the markets make now a great time to consider value and growth stocks. Learn more about our top 2 growth stocks for a bear market.